Loading
₹3,168.60
+11.90+0.38%today
Market closed · 7 Oct, 3:30 pm
+126.09%over 1 year
Today's range
₹3,136.10₹3,194.10
52-week range
₹1,380.10₹3,740.00
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 1,329 | 356 | 26.8% | 43.37 |
| FY25 | 1,000 | 159 | 15.9% | 19.81 |
| FY24 | 713 | 43 | 6.0% | 5.83 |
| FY23 | 613 | 83 | 13.6% | 11.43 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 32.66% | 32.66% | 32.66% | 32.66% |
| FIIs | 21.61% | 19.48% | 16.67% | 16.85% |
| DIIs | 19.56% | 19.60% | 21.70% | 22.59% |
| of which mutual funds | 14.17% | 13.86% | 15.11% | 15.81% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 26.16% | 28.24% | 28.96% | 27.89% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Dr. Lal Path Labs Ltd.LALPATHLAB | 1,938.00 | −1.33% | 32,529 |
| Krishna Institute of Medical Sciences Ltd.KIMS | 693.00 | −0.06% | 29,106 |
| Neuland Laboratories Ltd.NEULANDLAB | 21,610.00 | −1.35% | 27,725 |
| Piramal Pharma Ltd.PPLPHARMA | 202.67 | +1.07% | 26,982 |
| Rubicon Research Ltd.RUBICON | 1,570.00 | −1.68% | 25,989 |
| Acutaas Chemicals Ltd.ACUTAAS · this stock | 3,168.60 | +0.38% | 25,942 |
| Granules India Ltd.GRANULES | 845.80 | +1.12% | 20,959 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.